Adiponectin and Aldosterone in Left Ventricular Hypertrophy: An Intriguing Interplay

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Angiology

• Publication date

  2018-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0003319714527785PMID 24687414
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adiponectin as an Independent Predictor of Left Ventricular Hypertrophy in Nondiabetic Patients With Hypertension

  2015cited by this paper
• Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-β1/Smad signal pathway

  2014cited by this paper
• Association of Adiponectin Gene Polymorphism (+T45G) With Acute Coronary Syndrome and Circulating Adiponectin Levels

  2013cited by this paper
• Telmisartan as a metabolic sartan: the first meta-analysis of randomized controlled trials in metabolic syndrome.

  2013cited by this paper
• Renin-Angiotensin System Blockers Protect Pancreatic Islets against Diet-Induced Obesity and Insulin Resistance in Mice

  2013cited by this paper
• Is There Any Association Between Adiponectin Gene Polymorphisms and Cardiovascular Disease?

  2013cited by this paper
• Influence of serum adiponectin level and SNP +45 polymorphism of adiponectin gene on myocardial fibrosis

  2013cited by this paper
• Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients.

  2012cited by this paper
• Serum total adiponectin level and risk of cardiovascular disease in Han Chinese populations: a meta‐analysis of 17 case–control studies

  2012cited by this paper
• Treatment of primary aldosteronism: Where are we now?

  2011cited by this paper
• Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus

  2011cited by this paper
• Adipokines and Vascular Risk in Type 2 Diabetes Mellitus

  2011cited by this paper
• Effects of Improving Glycemic Control with Insulin on Leptin, Adiponectin, Ghrelin and Neuropeptidey Levels in Patients with Type 2 Diabetes Mellitus: a Pilot Study

  2011cited by this paper
• Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants.

  2010cited by this paper
• Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.

  2010cited by this paper
• Should adipokines be considered in the choice of the treatment of obesity-related health problems?

  2010cited by this paper
• Pharmacogenomic, Physiological, and Biochemical Investigations on Safety and Efficacy Biomarkers Associated with the Peroxisome Proliferator-Activated Receptor-γ Activator Rosiglitazone in Rodents: A Translational Medicine Investigation

  2010cited by this paper
• No effect of rosuvastatin on left ventricular hypertrophy in patients with hypertension: a prospective randomised open-label study with blinded endpoint assessment.

  2010cited by this paper
• Atorvastatin reverses cardiac remodeling possibly through regulation of protein kinase D/myocyte enhancer factor 2D activation in spontaneously hypertensive rats.

  2010cited by this paper
• Adipokines and cardiometabolic profile in primary hyperaldosteronism.

  2010cited by this paper
• Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study

  2010cited by this paper
• Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis.

  2009cited by this paper
• Expression of adiponectin receptors in mouse adrenal glands and the adrenocortical Y-1 cell line: adiponectin regulates steroidogenesis.

  2009cited by this paper
• Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

  2008cited by this paper
• Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

  2008cited by this paper
• Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia

  2008cited by this paper
• Adipose cell-adrenal interactions: current knowledge and future perspectives.

  2008cited by this paper
• Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome

  2007cited by this paper
• Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma.

  2007cited by this paper
• Adiponectin and insulin sensitivity in primary aldosteronism.

  2007cited by this paper
• Adiponectin receptor expression in the human adrenal cortex and aldosterone-producing adenomas.

  2006cited by this paper
• Insulin sensitivity in patients with primary aldosteronism: a follow-up study.

  2006cited by this paper
• Aldosterone and end-organ damage

  2005cited by this paper
• Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.

  2005cited by this paper
• Downloaded from http://circres.ahajournals.org / by guest on February 23, 2013Prevention of Cardiac Hypertrophy by Atorvastatin in a Transgenic Rabbit Model of Human

  2005cited by this paper
• Impaired Endothelium-Dependent Flow-Mediated Vasodilation in Hypertensive Subjects With Hyperaldosteronism

  2004cited by this paper
• Hypertension and Left Ventricular Hypertrophy : The 4 E Effects of Eplerenone , Enalapril , and Eplerenone / Enalapril in Patients With Essential

  2003cited by this paper
• Human adipocytes secrete mineralocorticoid-releasing factors

  2003cited by this paper
• Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects.

  2002cited by this paper
• Aldosterone Induces Angiotensin-Converting-Enzyme Gene Expression in Cultured Neonatal Rat Cardiocytes

  2001cited by this paper
• Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women.

  1999cited by this paper
• Inhibition by aldosterone of insulin receptor mRNA levels and insulin binding in U-937 human promonocytic cells.

  1999cited by this paper
• Effect of adrenal steroids on insulin release from cultured rat islets of Langerhans

  1986cited by this paper

• Characteristics and features of clinical manifestations of primary hyperaldosteronism (literature review)

  2019cites this paper
• Adiponectin attenuates kidney injury and fibrosis in deoxycorticosterone acetate-salt and angiotensin II-induced CKD mice.

  2018cites this paper
• Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism

  2016cites this paper
• Aldosterone is associated with left ventricular hypertrophy in hemodialysis patients

  2016cites this paper